UK Clinical Trials Gateway (UKCTG)

Welcome

12 February 2012

	Trial registration
	Unique identification scheme
	International databases

Find trials

ISRCTN

mRCT

Information

DUETS

DISCLAIMER

The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION

Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

UK trials

Showing records: 3391 to 3400 of 3810

SEARCH FOR	RESULTS ORDER	DIRECTION	MAX RESULTS	.

3391	Randomised phase II study of sequentially high dose Methotrexate and Fluorouracil combined with Epirubicin (FEMTX) versus FEMTX plus Cisplatin (FEMTX-P) in advanced gastric cancer
	ISRCTN:	ISRCTN69546136
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

3392	Phase III Randomised Study of High Dose Methotrexate and 5-Fluouracil Combined with Epirubicin (FEMTX) versus No Treatment in Stage II-III Resected Gastric Cancer
	ISRCTN:	ISRCTN71625775
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

3393	A Prospective Randomised Comparison of CMF versus Sequential Epirubicin Followed by CMF as Adjuvant Chemotherapy for Women with Early Breast Cancer
	ISRCTN:	ISRCTN35478997
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

3394	A phase II, double blind, randomised, dose ranging, safety and efficacy trial of rapid intravenous infusion of Zoledronate versus Aredia in breast cancer patients with osteolytic metastases
	ISRCTN:	ISRCTN29188871
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

3395	EURO-EWING 99: European Ewing Tumour Working Initiative of National Groups
	ISRCTN:	ISRCTN61438620
	Status:	Ongoing
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

3396	A Study to Compare the Safety and Efficacy of Durogesic with Sustained Release Morphine in Patients with Cancer Pain Transferring from Weak to Strong Opioids
	ISRCTN:	ISRCTN34797860
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

3397	A double-blind, placebo controlled study to assess the effects of early intervention and/or treatment with epoetin alfa on anaemia in cancer patients receiving non platinum containing chemotherapy
	ISRCTN:	ISRCTN98318971
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

3398	A Study Comparing CMF (Cyclophosphamide, Methotrexate, 5-fluorouracil) and MMM (Mitozantrone, Methotrexate, Mitomycin-C) Chemotherapy in Patients with Metastatic Breast Cancer
	ISRCTN:	ISRCTN92834934
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

3399	A placebo-controlled, double-blind, multicentre phase III trial to assess the efficacy and safety of miltefosine solution in the treatment of breast cancer where no other appropriate treatment is available
	ISRCTN:	ISRCTN91258120
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

3400	UKHAN1 - A Trial of Chemotherapy With Radiotherapy in the Treatment of Advanced Squamous Carcinoma of the Head and Neck
	ISRCTN:	ISRCTN93127929
	Status:	Completed
	Source of record:	UK trials (UK) - subset from ISRCTN Register, UK trials only

RESULT PAGE

340


© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. \| terms & conditions \| privacy statement